A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.

The minimum requirement for candidate human immunodeficiency virus (HIV) vaccines to enter clinical evaluation in humans should be their demonstrable immunogenicity in non-human primates: induction of antibodies neutralizing primary HIV isolates or elicitation of broad T cell-mediated immune respons...

書誌詳細
主要な著者:	Wee, E, Patel, S, Mcmichael, A, Hanke, T
フォーマット:	Journal article
言語:	English
出版事項:	2002

類似資料

Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
著者:: Hanke, T, 等
出版事項: (2005)

Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques.
著者:: Im, E, 等
出版事項: (2006)

Development of a DNA-MVA/HIVA vaccine for Kenya.
著者:: Hanke, T, 等
出版事項: (2002)

Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
著者:: Lynette Siv Chea, 等
出版事項: (2017-10-01)

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
著者:: Hanke, T, 等
出版事項: (2002)

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
著者:: Nixon, D, 等
出版事項: (2000)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
著者:: Wyatt LS, 等
出版事項: (2009-10-01)

Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques.
著者:: Michael Winkler, 等
出版事項: (2019-01-01)

DNA vaccines against human immunodeficiency virus type 1.
著者:: Estcourt, M, 等
出版事項: (2004)

Immune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1.
著者:: Vinner, L, 等
出版事項: (2006)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
著者:: Mwau, M, 等
出版事項: (2004)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
著者:: Sharpe, S, 等
出版事項: (2001)

Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance
著者:: Carol L. Vinton, 等
出版事項: (2019-12-01)

Electrostatic potential of human immunodeficiency virus type 2 and rhesus macaque simian immunodeficiency virus capsid proteins
著者:: Katarzyna eBozek, 等
出版事項: (2012-06-01)

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
著者:: Allen, T, 等
出版事項: (2000)

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
著者:: Hanke, T, 等
出版事項: (1999)

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice
著者:: Gabriela M. Escalante, 等
出版事項: (2024-09-01)

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
著者:: John D. Ventura, 等
出版事項: (2022-05-01)

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.
著者:: Hanke, T, 等
出版事項: (1999)

A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants
著者:: Afolabi, M, 等
出版事項: (2013)

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa.
著者:: Nkolola, J, 等
出版事項: (2004)

Tissue-Specific DNA Methylation Changes in CD8<sup>+</sup> T Cells During Chronic Simian Immunodeficiency Virus Infection of Infant Rhesus Macaques
著者:: Mukta Nag, 等
出版事項: (2024-11-01)

Downregulation of CCR5 on brain perivascular macrophages in simian immunodeficiency virus‐infected rhesus macaques
著者:: Julian B. Hattler, 等
出版事項: (2023-08-01)

Simian immunodeficiency virus-infected rhesus macaques with AIDS co-develop cardiovascular pathology and encephalitis
著者:: Kevin S. White, 等
出版事項: (2023-10-01)

A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants.
著者:: Muhammed O Afolabi, 等
出版事項: (2013-01-01)

Correction: MVA.85A Boosting of BCG and an Attenuated, Deficient Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques.
著者:: Frank A. W. Verreck, 等
出版事項: (2011-01-01)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
著者:: Alice Berger, 等
出版事項: (2024-03-01)

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.
著者:: Vinner, L, 等
出版事項: (2003)

Evidence for an Increased Risk of Transmission of Simian Immunodeficiency Virus and Malaria in a Rhesus Macaque Coinfection Model
著者:: Trott, KA, 等
出版事項: (2011)

Toll-like Receptor 2 Mediated Immune Regulation in Simian Immunodeficiency Virus-Infected Rhesus Macaques
著者:: Nongthombam Boby, 等
出版事項: (2023-12-01)

Enhanced Intestinal TGF-β/SMAD-Dependent Signaling in Simian Immunodeficiency Virus Infected Rhesus Macaques
著者:: Nongthombam Boby, 等
出版事項: (2021-04-01)

Early Detection of Simian Immunodeficiency Virus in the Central Nervous System Following Oral Administration to Rhesus Macaques
著者:: Jeffrey M Milush, 等
出版事項: (2013-08-01)

Optimizing Delivery of the HIVconsv Immunogen in Rhesus Macaques
著者:: Rosario, M, 等
出版事項: (2011)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
著者:: White, A, 等
出版事項: (2013)

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
著者:: Borthwick, N, 等
出版事項: (2015)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
著者:: Rosario, M, 等
出版事項: (2010)

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.
著者:: Hanke, T, 等
出版事項: (1998)

Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.
著者:: Rosario, M, 等
出版事項: (2010)

Mayaro virus pathogenesis and immunity in rhesus macaques.
著者:: Whitney C Weber, 等
出版事項: (2023-11-01)

Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.
著者:: Estcourt, M, 等
出版事項: (2005)